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ABSTRACT 
The major energy generator in the cell – mitochondria produce reactive oxygen species as 
a by-product of a number of enzymatic reactions and ATP production. Emerging 
evidence suggests that mitochondrial ROS regulate diverse physiological parameters and 
that dysregulated ROS signalling may contribute to a development of pathologies which 
leads to human diseases. ROS produced in mitochondrial enzymes are trigger for 
monoamine-induced calcium signal in astrocytes, playing important role in physiological 
and pathophysiological response to dopamine. Generation of ROS in mitochondria leads 
to peroxidation of lipids, which is considered to be one of the most important mechanisms 
of cell injury under condition of oxidative stress. However, it also can induce activation of 
mitochondrial and cellular phospholipases that can trigger variety of the signals – from 
activation of ion channels to stimulation of calcium signal. Mitochondria are shown to be 
the oxygen sensor in astrocytes, therefore inhibition of respiration by hypoxia induces 
ROS production which leads to lipid peroxidation, activation of phospholipase C and 
induction of IP3-mediated calcium signal. Propagation of astrocytic calcium signal 
stimulates breathing activity in response to hypoxia. Thus, ROS produced in 
mitochondrial enzymes or electron transport chain can be used as a trigger for signalling 
cascades in central nervous system and deregulation of this process leads to pathology.  
Introduction  
Although mitochondria have a multiple important functions, this organelle is mainly high 
efficient engine for conversion of the products of glucose or fatty acid metabolism into 
universal form of energy which is accepted by all types of cells – ATP. As in every highly 
efficient engine, the process of ATP production in the oxidative phosphorylation coupled with 
the mitochondrial respiration in the electron transport chain is having a leakage of energy in the 
form of electrons. These outgoing electrons can hit the nearby situated molecules and 
ultimately produce free radicals. Mitochondria are using most of the oxygen taken up by the 
cell and considering this oxygen-rich environment, the production of Reactive Oxygen Species 
(ROS) is inevitable. Electrons escaping the electron transport chain in the first instance 
generate ROS mainly in the form of super oxide radical O2
.-
. This superoxide converts to 
hydrogen peroxide (Boveris et al., 1972; Loschen et al., 1971; Loschen et al., 1974). 
Compared to the activated enzymes such as NADPH or xanthine oxidases mitochondria 
produce less ROS, but in contrast to any other enzymatic and non-enzymatic ROS producer, 
this organelle is able to generate free radicals continually (Gandhi and Abramov, 2012). 
Considering the high reactivity and toxicity of ROS, our cells (and particularly the 
mitochondria) in the time of evolution have not only developed effective defence systems 
against oxidative damage but also adopted ROS to play signalling and regulatory role in 
physiological processes.   
The rate of production and the level of ROS produced by mitochondria can be modulated by a 
number of factors that render this system to be an ideal regulatory instrument in the cellular 
homeostasis and to be a messenger in the signal transduction cascades.  
In the following review we discuss the physiological role of ROS produced in the mitochondria 
and how deregulation of this process can lead to development of pathology and become trigger 
of cell death (which is as well one of the multiple mitochondrial functions).    
Mitochondrial ROS producers 
In the majority of publications under the term “mitochondrial ROS” the authors mean the ROS 
produced in the electron transport chain (ETC) of mitochondria. ROS in mitochondria can be 
formed by enzymatic action of numerous enzymes including monoamine oxidase (MAO) and 
cytochrome b5 reductase (Cb5R) located on the outer mitochondrial membrane, as well as 
glycerol-3-phosphate dehydrogenase and in some cell types, various cytochrome P450 
enzymes located in the inner mitochondrial membrane. There are also several matrix enzymes 
and complexes including aconitase, pyruvate dehydrogenase (PDH), and α-ketoglutarate 
dehydrogenase (αKGDH) that can generate superoxide (Finkel, 2011). Superoxide can rapidly 
dismutate spontaneously or enzymatically with the help of manganese superoxide dismutase 
(MnSOD). The formed freely permeable H2O2 can be further degraded by enzymes such as 
catalase (CAT), glutathione peroxidase (GPx), and peroxiredoxin 3 (Prx3) (Brand, 2010). 
Production of ROS in the ETC 
The main source of reactive oxygen species in the mitochondria is the electron leak from the 
electron transport chain (ETC). Depending on the direction of the electron “escape” from ETC, 
ROS (mainly superoxide anion; O2
.-
) is produced in the matrix or between inner and outer 
membrane of mitochondria (Figure 1). Electron transport between the complexes of the 
electron transport chain is limited by the availability of substrates for this complexes (NADH 
and succinate), but also on the rate of production of substrates in the TCA cycle, the rate of 
consumption of ATP and/or on availability of the final electron acceptor (oxygen) of the 
electron transport. However, ROS production that is linked to the topology of the electron 
carriers and their functional integration is determined by the rate constants of the enzymatic 
reactions of the complexes of the electron transport chain. Moreover, ROS production is 
dependent on the values of the mitochondrial membrane potential (Starkov and Fiskum, 2003; 
Votyakova and Reynolds, 2001). The leak of electrons can be induced by inhibition of complex 
I and III with specific inhibitors (e.g. rotenone and antimycin A), that lead to a higher rate of 
reactive oxygen production in the mitochondria (Lenaz, 2001; Murphy, 2009). Inhibition of 
respiration and decrease of mitochondrial membrane potential by anoxia or hypoxia can 
stimulate ROS production in the same way but only for short time (Abramov et al., 2007; Nohl 
et al., 1993). High mitochondrial membrane potential also increases a rate of ROS production 
in ETC and it can be elevated by application of the mitochondrial substrates (Abramov et al., 
2010; Kovac et al., 2015). Mild uncoupling with low doses of FCCP or physiological 
uncouplers significantly reduces production of superoxide and for long time is used as a basis 
for cell protective strategy (Brennan et al., 2006; Skulachev, 1996). Although the use of 
chemical uncouplers reduced mitochondrial ROS production, the decrease of oxidative stress in 
general may be limited because FCCP on the other hand can maximise superoxide production 
in activated NADPH oxidase (Abramov et al., 2005). Thus, the rate of ROS production in ETC 
can be manipulated by changing the mitochondrial membrane potential, using inhibitors and 
substrates of the mitochondrial enzymatic complexes.  
ROS production in the matrix of mitochondria – TCA  
It has been confirmed that ROS production in mitochondria takes place as well outside the 
electron transport chain: isolated α-ketoglutarate dehydrogenase (KGDHC; the rate-limiting 
enzyme of the TCA cycle) or pyruvate dehydrogenase complexes (PDHC) are producing 
superoxide or hydrogen peroxide in the absence of ETC complex inhibitors (Starkov et al., 
2004). Interestingly, despite generating ROS, α-ketoglutarate dehydrogenase complex is on the 
same time very sensitive to oxidative stress, e.g. peroxynitrite inhibited purified KGDHC 
activity in a dose-dependent manner and its activity could be restored by GSH (Shi et al., 
2011). KGDHC can be also inactivated by hydrogen peroxide in bovine cardiac mitochondria, 
fibroblasts or N2 cells (Figure 1). Moreover, inhibition of KGDHC by hydrogen peroxide 
limits the amount of NADH available to the complex I from the respiratory chain (Tretter and 
Adam-Vizi, 2000; Tretter and Adam-Vizi, 2004). Reduced activity of brain α-ketoglutarate 
dehydrogenase complex occurs in a number of neurodegenerative diseases like Parkinson's 
disease and Alzheimer's disease, where oxidative stress is thought to be central to the 
pathophysiology of these diseases (Gibson et al., 2003; Gibson et al., 2005; Gibson et al., 
2012). Further, in mitochondria the succinate dehydrogenase (SDH) complex as well is capable 
of superoxide production in the absence of an electron acceptor (Zhang et al., 1998).  
ROS produced at the outer membrane of mitochondria  
 One of the most effective pharmacological targets in neurology is the mitochondrially located 
(outer membrane) family of enzymes monoamine oxidase (MAO; Figure 1). MAO catabolises 
dietary monoamines through oxidative deamination, producing aldehydes and H2O2 (Hare, 
1928). ROS production in the form of hydrogen peroxide can be stimulated by catabolism of 
monoamines from food or generally in the homeostasis of neurotransmitters and 
neuromodulators – dopamine, serotonin and adrenaline (Barchas and Freedman, 1963). There 
are possible intercommunications between ROS from MAO and ETC – deficiency in MAO-A 
reveals protection against inhibitors of mitochondrial complexes I, III and IV (Fitzgerald et al., 
2014).  
Regulatory role of mitochondrial ROS 
Mitochondrial ROS as activators of phospholipases 
Phospholipases play housekeeping and signalling role in the cells. It has been demonstrated 
that ROS production could activate phospholipases (van Rossum et al., 2004). This activating 
effect has been shown for different form of ROS including the product of oxidative stress – 
lipid peroxidation (Hermann et al., 2014; Marzoev et al., 1987; Timusheva et al., 1998). Lipid 
peroxidation is affecting different isoforms of phospholipase A in mitochondria, cytosol and 
lysosomes. Stimulating effect of lipid peroxidation has been also shown for phospholipase D 
(Natarajan and Garcia, 1993) and, importantly for phospholipase C (Domijan et al., 2014; 
Rossi et al., 1994). We have recently shown that only lipids that are oxidized can be used as a 
substrate for the phospholipase C (Domijan et al., 2014). This is a natural process by which 
damages in the membranes are repaired and further imply a possibly important role of PLC as a 
part of the cellular antioxidant defence system and the role of ROS and lipid peroxidation in 
calcium signalling by producing IP3.  Confirming this, mutation and loss of phospholipase 
activity lead to increased lipid peroxidation in mitochondria and cytosol and can be a trigger of 
neurodegeneration (Kinghorn et al., 2015). Overproduction of lipid peroxidation is described 
for various types of pathology (Angelova et al., 2015a) playing an important role in 
cytochrome c release from mitochondria in initiation of cell death (Kagan et al., 2005).  
Role of ROS in signal transduction 
It has been observed that application of low doses of hydrogen peroxide to the cells induces 
calcium signal (Domijan et al., 2014; Gonzalez-Pacheco et al., 2002; Granados et al., 2007). 
Considering this, activation of endogenous ROS formation in mitochondria should play an 
important role in the initiation of signal transduction. Thus, dopamine-induced calcium signal 
in astrocytes is due to production of ROS in MAO and it can be blocked by molecular or 
pharmacological inhibition of this enzyme or by application of antioxidants (Vaarmann et al., 
2010). Generation of hydrogen peroxide in MAO stimulates lipid peroxidation, activation of 
phospholipase C and generation IP3-dependent calcium signal (Vaarmann et al., 2010) 
confirming the important role of mitochondrial ROS in signal transduction in CNS. 
An important role for ROS has been shown for modulation of various ion channels (BK, KCN, 
ERG, TRP, etc.) and consequently for the regulation of the neuronal and cardiomyocyte 
excitability (Angelova and Muller, 2006; Angelova and Muller, 2009; Hool and Corry, 2007; 
Liu and Gutterman, 2002; Tang et al., 2001). Changes in the intracellular redox milieu can 
affect many physiological processes, e.g. the gating properties of ion channels and the activity 
of certain transport mechanism and therefore it could play an essential role in the cellular signal 
transduction process in a variety of systems.  Cysteine or methionine residues on diverse 
(principal or auxiliary) channel and receptor protein subunits could act as redox–sensitive 
switches and thus ROS could modulate the activity of these proteins (Ciorba et al., 1997; Kolbe 
et al., 2010; Tang et al., 2004). For example, ryanodine receptor (RyR) and Ca
2+
 channels 
activity from the sarcoplasmic reticulum (SR) in the heart can be modulated by both ROS and 
RNS and therefore has a profound effect on the proper cardiac function and on the 
development of a pathophysiological condition (cardiac failure) (Zima and Blatter, 2006). 
In fact ROS exert general signalling role in normal physiological processes as in many studies 
application of antioxidants to a system at rest or non-pathology actually attenuates the normal 
function of neuronal or cardiac cell excitability for example (Angelova and Muller, 2006; Wei 
et al., 1998) 
Thus, mitochondrial ROS (and RNS), produced in this highly dependent on the redox potential 
milieu, are very likely to be involved in the regulation of mitochondrial ion channels and 
transporters (Uchi et al., 2014). 
 
Physiological function of mitochondrial ROS – regulation of breathing 
We have recently discovered a physiological role for astrocytes in regulation of breathing, 
appointed till recently only for the glomus cells from the carotid body (Angelova et al., 2015b). 
Astrocytes from the brain stem or also from the cortex were able to sense directly even slight 
decrease in partial pressure of atmospheric oxygen (from 21% to 15% ppO2). Astrocytes from 
either primary culture, organotypic culture, acute brain slice or somatosensory cortex in vivo in 
anesthetised animal were able to respond to argon-induced hypoxia in physiological variation 
range with rise in cytosolic calcium under the form of sustained [Ca
2+
]i, elevation, calcium 
oscillations or combination of both. More important, the threshold for astroglial activation of a 
calcium signal in the cortex lies at about 10 mmHg lower than the value for activation of the 
signal in glomus cells from the carotid body (37mmHg). Calcium signal evoked in astrocytes 
was reliably mimicked in chemical model of hypoxia (consumption of molecular oxygen by 
sodium dithionite (SDT) and not dependent on the activation of P2Y1 purinergic receptors, as 
shown for astrocytes pre-incubated with MRS2179 (a metabotropic ATP receptor antagonist). 
The mitochondrion is the location where oxygen consumption ultimately takes place, for this 
reason we hypothesised that the sensor for astrocytic oxygen sensing resides in the 
mitochondria. Interestingly, in our simultaneous experiments of measurement of cytosolic 
calcium by fura-2 and Δψm by Rh123, each calcium spike was preceded well in advance (~30s 
or until mitochondrial depolarization reaches maximum drop for this condition) by a massive 
mitochondrial depolarization (~70%) which was reversible if episodes of hypoxia lasted no 
more than 2 min. Moreover, when we slightly depolarized mitochondria with 0.5 μM FCCP 
prior to induction of hypoxia, no more calcium signal could be evoked in astrocytes in vitro as 
well in vivo experiments. To double-prove this finding, we have used PINK1 (PTEN-induced 
kinase 1; a Parkinson’s disease related gene) KO mouse astrocytes with well-established 
reduction of mitochondrial membrane potential as a bioenergetic consequence of the mutation 
and main feature of the disease (Abramov et al., 2011; Gandhi et al., 2009). As expected, no 
calcium signal could be evoked upon application of argon for 2 min (mild hypoxia). All this 
data point towards a certain threshold value for mitochondrial depolarization, that is necessary 
to be achieved at once, in order to trigger an astrocytic calcium response (Figure 2).  
Delay in the rate of proton pumping by the enzymatic complexes of the electron transport chain 
will logically result in congestion of the electron transfer and thus in inhibition of 
mitochondrial respiration and consequently will enable the production of reactive oxygen 
species (Murphy, 2009) by the collision of unpaired electrons with the surrounding molecules 
(lipids, proteins). In (Angelova et al., 2015b), we have unravelled the mechanism of oxygen 
sensing of astrocytes to engage as a major step the production of mitochondrial ROS. In 
experiments with MitoSOX we clearly show that superoxide is produced upon induction of 
mild hypoxia and the rate of ROS production could be set back to basal be depolarizing the 
mitochondria with 0.5 μM FCCP or could be completely abolished by application of 
mitochondrial-targeted ROS scavenger MitoQ (Kelso et al., 2001). In fact, further step to lipid 
peroxidation is involved when the partial oxygen pressure PO2 was lowered, as measured in 
C11-BODIPY experiments in astrocytes. Again, the rate of lipid peroxidation remained at basal 
when astrocytes were pre-treated with 0.5 μM FCCP to slightly depolarize mitochondria prior 
to the hypoxia onset. Moreover, calcium signal that has been evoked by hypoxic condition in 
astrocytes have been completely abolished by the application of MitoQ or Vit.E, which affirms 
the finding that mitochondrial ROS are able to trigger calcium signalling event in response to 
altered atmospheric oxygen in astrocytes (Figure 2).  
Thus, we have been able to show the mechanism by which astrocytes are able to sense 
physiological changes in brain oxygenation and astrocytic mitochondria being the physical 
place of the CNS oxygen sensors. 
Conclusion remarks 
For long time reactive oxygen species have been considered to be by-products of biological 
reactions that are highly aggressive and damaging to the surrounding tissue. It is necessary to 
accentuate on the fact that ROS are not cellular waste products, but actually signalling 
molecules that are very important for proper functioning of the organism, including 
proliferation, differentiation, aging, transcription factor regulation, inflammation, and other 
regulatory functions. 
There are no doubts that mitochondrial ROS are involved in the mechanism of acute (i.ie. 
anoxia) or chronic pathology (i.e. neurodegeneration) but because of important implication of 
mitochondrial ROS in physiology, more accurately developed strategy for treatment with ROS 
scavengers and mitochondrially targeted antioxidants should be used.  
Moreover, it should also be pointed out that lipid peroxidation which has always been accepted 
as a marker for late oxidative stress has an essential role as a source of substrates and as an 
activator of phospholipases, thus playing an important role in cells housekeeping and 
signalling.  
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Figure Legend 
Figure 1. Schematic representation of the major mitochondrial ROS producers and 
targets. 
Figure 2. Mechanism of oxygen sensing in astrocytes.  
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